KimDickinsonMD

Cytopathology, Anatomic Pathology, Clinical Pathology

Physician

Are you Dr. Dickinson?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Connect with colleagues in the same hospital or clinic
You already have 33 invites waiting!
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

Dr. Kim Dickinson, MD is a board certified pathologist in Monterey Park, California. She is currently licensed to practice medicine in California.

University of Southern California/LAC+USC Medical CenterResidency, Pathology-Anatomic and Clinical, 1988 - 1992
University of Southern California/LACUSC Medical CenterInternship, Transitional Year, 1986 - 1987
Drexel University College of MedicineClass of 1986

PubMed

57 citations
American Telemedicine Association clinical guidelines for telepathology.
Liron Pantanowitz, Kim Dickinson, Andrew Evans, Lewis A. Hassell, Walter H. Henricks, Jochen K. Lennerz, Amanda Lowe, Anil V. Parwani, Michael Riben, Daniel Smith, J. ...> ;Journal of Pathology Informatics. 2014 Jan 1
Population pharmacokinetic modeling and dosing simulations of nitrogen-scavenging compounds: disposition of glycerol phenylbutyrate and sodium phenylbutyrate in adult ...
Monteleone, J. P.,Mokhtarani, M.,Diaz, G. A.,Rhead, W.,Lichter-Konecki, U.,Berry, S. A.,Lemons, C.,Dickinson, K.,Coakley, D.,Lee, B.,Scharschmidt, B. F.> ;J Clin Pharmacol. 2013 Jul
30 citations
Urinary phenylacetylglutamine as dosing biomarker for patients with urea cycle disorders.
, , , , , , , , , , , , , , , , , , , , , , , , , , , , > ;Molecular Genetics and Metabolism. 2012 Nov 1